Skip to main content

MedBrevia

Loading…

Skip to main content

Built by clinicians, backed by citations, privacy-first. No ads.

Literature Search

Search millions of biomedical articles with AI filters.

Clinical Trials Explorer

Search ClinicalTrials.gov studies by condition, intervention, eligibility, and results.

Chat

Ask questions and get citable answers from our literature corpus.

Grand Rounds Dashboard

Synthesis of the latest research in your field.

Saved Library

Bookmark, tag, and annotate papers.

Medical Calculators

CHA2DS2-VASc, MELD-Na, ASCVD, Wells, and more.

Back to Grand Rounds

Grand Rounds

Nuclear Medicine weekly archive

Use of radioactive substances in the diagnosis and treatment of disease.

Browse by year

Latest issue

Jul 4

Selected recent studies affecting AI, radiomics, and bias in oncology care and trials

Generative AI-enabled clinical decision support system in primary care: a pragmatic, cluster-randomized trial.Family experiences of receiving treatment recommendations in a precision medicine trial for poor-prognosis childhood cancer.

Browse Grand Rounds

2025 issues

Nuclear MedicineAll yearsLatest first

2025

Dec 27

Issue 01

Weekly Grand Rounds

Precision PET and SPECT tracers to refine oncologic risk, inflammation, and systems imaging

The value of PSMA PET for risk stratification in prostate cancer: an update and future aspects.Higher Preoperative Maximum Standardised Uptake Values Are Associated with a Higher Risk of Metastases After Robot-assisted Radical Prostatectomy for Patients Undergoing 68Ga-PSMA-11 and 18F-DCFPyL Positron Emission Tomography/Computed Tomography.

December 27, 2025

Dec 20

Issue 02

Weekly Grand Rounds

Targeted PET and theranostics to refine oncologic imaging and radionuclide therapy

[18F]-Fluciclovine or [68Ga]-PSMA-11 Molecular Imaging To Guide Dose Escalation of Salvage Radiotherapy After Radical Prostatectomy for Prostate Cancer: The EMPIRE-2 Trial.Diagnostic Accuracy of [18F]FDG PET/CT versus CT for NSCLC Surveillance: Secondary Analysis of a Randomized Clinical Trial.

December 20, 2025

Dec 13

Issue 03

Weekly Grand Rounds

Practice-shaping advances in oncologic PET: surveillance, staging, and tracer selection

Diagnostic Accuracy of [18F]FDG PET/CT versus CT for NSCLC Surveillance: Secondary Analysis of a Randomized Clinical Trial.Prostate-specific Membrane Antigen Positron Emission Tomography Versus Conventional Imaging for Preoperative Staging High-risk Prostate Cancer Patients Undergoing Surgery for cN0M0 Disease: An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study.

December 13, 2025

MedBrevia

Accelerating clinical insights with clinical research to support evidence-based medicine.

Product

Search
Grand Rounds
Calculators

Account

Dashboard
Signup

Legal

Privacy Policy
Terms of Service
Cookie Preferences
Disclaimer

© 2026 MedBrevia. All rights reserved.

Twitter LinkedIn Blog RSS